Pfizer to ask FDA to authorize second booster for adults 65 plus

Pfizer will ask the Food and Drug Administration (FDA) to authorize a second COVID-19 vaccine booster dose for adults over the age of 65, two people familiar with the situation told The New York Times.The sources said the company could request the…